Lexaria Biosciences Corp. (CSE: LXX) (OTCQB: LXRP), a biosciences company that has developed delivery technologies to improve absorption of bioactive compounds, has enhanced the ability of cannabinoid-products companies to deliver active ingredients to the body with its patent-protected technology.
mCig, Inc. (OTCQB: MCIG), a diversified company servicing the legal cannabis markets, enters into the cryptocurrency market, partnering with Render Payment during its Pre-ICO (Initial Coin Offering).
India Globalization Capital (NYSE MKT: IGC) recently announced that it is assembling a line of cannabis-based medical dispensary products targeting Alzheimer’s disease.
Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX) this morning announced the launch of the first cryptocurrency daily video newscast in the Chinese language broadcast from the NYSE.
People with such serious medical conditions as glaucoma and multiple sclerosis may smoke marijuana to deliver a range of chemicals that they believe helps improve their conditions. The problem is that a joint might just be one of the least effective methods to deliver some of the 90+ cannabinoids found in cannabis.
Organigram Holdings Inc. (TSX VENTURE:OGI) (OTCQB:OGRMF) is undergoing a production-facility expansion that will more than triple the size of its operations. The multi-million-dollar project will meet the growing needs of the Company’s medical patient base, as well as prepare Organigram for the legal, adult-recreational marijuana market.
BC Bud. BC Tweed. Canopy Growth establishes joint venture to convert 1.3 million square feet of existing greenhouse in British Columbia. The joint venture includes an option for additional 1.7 Million sq. ft. greenhouse.
ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) was one of the first companies to obtain a cannabis production license in Canada, and it continues going strong among the country’s limited number of licensed growers—only 62 to date.
Further scientific validation will be icing on the cake for ChineseInvestors.com, Inc. (OTCQB: CIIX).
InMed Pharmaceuticals, Inc. (CSE: IN; OTCQB: IMLFF), announces the addition of Dr. Mauro Maccarrone to its Scientific Advisory Board. Dr. Maccarrone has vast experience in the field of cannabinoid research.
PotNetwork Holding, Inc. (OTC: POTN) this morning announced its appointment of Dr. Michael McKenzie, an industry-leading physician, to its advisory board.
SeeThruEquity has updated its coverage and maintained its price target of $3.75 on shares of ChineseInvestors.com, Inc.’s (OTCQB: CIIX) stock.
India Globalization Capital, Inc. (NYSE American: IGC) this morning provided an update on compelling in vitro data compiled from genetically engineered cell lines within an Alzheimer’s disease model showing that, at varying concentrations of IGC-AD1, mitochondrial function is enhanced by 30-60 percent.
InMed Pharmaceuticals, Inc. (CSE: IN; OTCQB: IMLFF), has more major news today as they have filed a provisional patent for pain program. This is a huge step in protecting intellectual and commercial property related to their groundbreaking research into the potential of non-THC cannabinoids to treat pain using a topical formulation..
Pioneering biotechnology company Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) has developed a breakthrough lipid-based system that facilitates more efficient delivery of bioactive compounds—not only enhancing bio-absorption and bioavailability but also improving taste, smell and the onset of action.
